Browsing by Author Lim, TH

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 4 to 8 of 8 < previous 
TitleAuthor(s)Issue DateViews
 
Preliminary safety and antiviral activity of VIR-2218, an X-targeting HBV RNAi therapeutic, in chronic hepatitis B patients
Proceeding/Conference:Journal of Hepatology
Gane, ELim, YSTangkijvanich, PO'Beirne, JLim, THBakardjiev, ADing, XConnolly, LHuang, SKim, JPang, PYuen, RMF
2020
56
 
RO7062931 antisense oligonucleotide phase 1 study demonstrates target engagement in patients with chronic hepatitis B on established nucleos(t)ide therapy
Proceeding/Conference:Journal of Hepatology
Yuen, RMFGane, EKim, DJChan, HSurujbally, BPavlovic, VTriyatni, MGrippo, JKim, HJLeerapun, ALim, THLim, YSTanwandee, TKim, WCheng, WHu, THWat, C
2020
14
 
Short term RNA interference therapy in chronic hepatitis B using JNJ-3989 brings majority of patients to HBsAg < 100 IU/ml threshold
Proceeding/Conference:Journal of Hepatology
Yuen, RMFLocarnini, SLim, THStrasser, SSievert, WCheng, WThompson, AGiven, BSchluep, THamilton, JCloherty, GWong, DKHSchwabe, CJackson, KFerrari, CLai, CLGish, RGGane, E
2019
47
 
Short-term treatment with RNA interference therapy, JNJ-3989, results in sustained hepatitis B surface antigen suppression in patients with chronic hepatitis B receiving nucleos(t)ide analogue treatment
Proceeding/Conference:Journal of Hepatology
Gane, ELocarnini, SLim, THStrasser, SSievert, WCheng, WThompson, AGiven, BSchluep, THamilton, JBiermer, MKalmeijer, RBeumont-Mauviel, MLenz, OCloherty, GWong, DKHSchwabe, CJackson, KFerrari, CLai, CLGish, RGYuen, RMF
2020
32
 
Tissue distribution of orally administered bismuth in the rat
Journal:Clinical and Experimental Pharmacology and Physiology
Lee, SPLim, THPybus, JClarke, AC
1980
56
Showing results 4 to 8 of 8 < previous